Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.22.4
Consolidated Balance Sheets (Parentheticals) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Accounts receivable, net of allowance for credit losses (in Dollars) $ 900 $ 500
Ordinary shares, nominal value (in Dollars per share) $ 0.01 $ 0.01
Ordinary shares, authorized 180,000,000 180,000,000
Ordinary shares, issued 67,086,000 65,677,000
Ordinary shares, outstanding 67,086,000 65,677,000